Dynavax Technologies Corp (NASDAQ:DVAX)

28.83
Delayed Data
As of Jul 28
 +0.28 / +0.98%
Today’s Change
13.10
Today|||52-Week Range
29.93
+71.00%
Year-to-Date

Today’s Trading

Previous close28.55
Today’s open28.47
Day’s range27.45 - 28.97
Volume564,238
Average volume (3 months)510,351
Market cap$955.6M
Dividend yield--
Data as of 3:59pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-8.44%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book7.47

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+1.17+5.84%
PDLIPDL BioPharma Inc+0.02+0.43%
ARNAArena Pharmaceutical...+0.09+2.26%
ZFGNZafgen Inc+1.94+5.52%
Data as of 3:59pm ET, 07/28/2015

Financials

Last reporting dateJuly 28, 2015
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers